Ocular Therapeutix’s lead asset is Axpaxli, being developed for wet age-related macular degeneration. A Phase III study is ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Central vision can fade slowly with age-related macular degeneration. Faces blur. Words smear on a page. A dark spot can sit ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

If you don't like getting needles in the arm, imagine getting them in your eyes. That's what people with wet age-related macular degeneration have to do, but thanks to new research, those injections ...

During the past few years, there have been tremendous advances in the treatment of several significant eye diseases, including macular degeneration, thyroid eye disease and eye infection. Macular ...

Medically reviewed by Christine L. Larsen, MD Key Takeaways Macular degeneration is a common eye disease, affecting more than 19 million people in the United States alone.The condition can reduce a ...

Geographic atrophy (GA) is one of two kinds of advanced age-related macular degeneration (AMD). It’s an eye disease that damages cells in the central part of your retina called the macula. Late-stage ...

A macular hole is when an opening forms in the middle of the light-sensitive tissue at the back of the eye. It can lead to people having a blurry or black spot in the center of their vision. The ...